ChemicalBook > CAS DataBase List > SGI-1027
SGI-1027
SGI-1027
- CAS No.1020149-73-8
- Chemical Name:SGI-1027
- CBNumber:CB42663344
- Molecular Formula:C27H23N7O
- Formula Weight:461.52
- MOL File:1020149-73-8.mol
SGI-1027 Property
- Melting point >280℃
- Density 1.387±0.06 g/cm3(Predicted)
- storage temp. 2-8°C
- solubility Soluble in DMSO (up to 35 mg/ml)
- pka 13.31±0.70(Predicted)
- form powder
- color white to light brown
- Stability Stable for 2 years as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
- UNSPSC Code 12352200
- NACRES NA.77
- Symbol(GHS)
- Signal word
- Hazard statements
- Precautionary statements
SGI-1027 Price
More Price(2)
- Brand: Sigma-Aldrich(India)
- Product number: SML1358
- Product name : SGI-1027
- Purity: ≥98% (HPLC)
- Packaging: 5MG
- Price: ₹13908.3
- Updated: 2022/06/14
- Buy: Buy
- Brand: Sigma-Aldrich(India)
- Product number: SML1358
- Product name : SGI-1027
- Purity: ≥98% (HPLC)
- Packaging: 25MG
- Price: ₹55932.9
- Updated: 2022/06/14
- Buy: Buy
SGI-1027 Chemical Properties,Usage,Production
- Description SGI-1027 is a DNMT inhibitor with IC50 of 6, 8, 7.5 μM for DNMT1, DNMT3A, and DNMT3B in cell-free assays, respectively.
- Features Potential for use in epigenetic cancer therapy.
- In vitro SGI-1027 inhibits DNA methylation by directly inhibiting DNMTs, and results in selective degradation of DNMT1 in a wide variety of human cancer cell lines. SGI-1027 exhibits minimal or no cytotoxic effect in rat hepatoma H4IIE cells. SGI-1027 (0-100 μM) exhibits a moderate pro-apoptotic effect on U937 human leukemia cell line with no relevant changes on the cell cycle.
- Description SGI-1027 (1020149-73-8) is a potent and selective inhibitor of DNA methyl transferase inhibiting DNMT1, DNMT3A and DNMT3B with comparable potency (IC50=12.5, 8.0 and 7.5 mM respectively).1? Treatment of various cancer cell lines with SGI-1027 results in selective degradation of DNMT1 (MG-132 sensitive) with minimal effect on DNMT3A and 3B at 2.5-5 mM.1 Prolonged treatment of RKO cells resulted in reexpression of silenced tumor suppressor genes.1 Synergizes with doxorubicin at growth inhibition in neuroblastoma cell lines.2 Disrupts the MKK3-MYC complex in cells and inhibits MYC transcriptional activity in colon and breast cancer cells.3
- Uses SGI-1027 is a quinoline derivative and a potent inhibitor of DNA methyltransferase (DNMT). SGI-1027 can be used as a potential therapeutic agent for the treatment of cancer and other diseases and also as a research tool to investigate the role of DNMTs in epigenetic events.
- Biochem/physiol Actions SGI-1027 is a DNA methyltransferase (DNMT) inhibitor with IC50 values of 6-13 μM for DNMT3B, DNMT3A and DNMT1. SGI-1027 directly inhibits DNMT activity by competing with the cofactor, S-adenosylmethionine (SAM) in the methylation reaction. SGI-1027 treatment of cancer cell lines induced degradation of DNMT1, but not DNMT3A or DNMT3B, and in RKO cells caused re-expression of the silenced tumor supressor genes p16, MLH1 and TIMP3.
- target DNMT1
- storage Store at -20°C
- References Datta et al. (2009), A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation; Cancer Res., 69 4277 Penter et al. (2015) A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma; Target Oncol., 10 523 Yang et al. (2021), Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer; Bioorg. Chem., 45 116324
SGI-1027 Preparation Products And Raw materials
Raw materials
Preparation Products
Global(101)Suppliers
-
Supplier:
- Tel:+undefined-21-51877795
- Email:ivan@atkchemical.com
- Country:China
- ProdList:33024
- Advantage:60
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32159
- Advantage:58
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:laboratory@coreychem.com
- Country:China
- ProdList:30230
- Advantage:58
-
Supplier:
- Tel:86-571-88216897,88216896<br/>13588875226
- Email:sales@hzclap.com
- Country:CHINA
- ProdList:6312
- Advantage:58
-
Supplier:
- Tel:+86-29-89586680<br/>+86-15129568250
- Email:1026@dideu.com
- Country:China
- ProdList:22854
- Advantage:58
-
Supplier:
- Tel:+1-2135480471<br/>+1-2135480471
- Email:sales@sarms4muscle.com
- Country:China
- ProdList:10473
- Advantage:58
-
Supplier:
- Tel:+1-708-310-1919<br/>+1-13798911105
- Email:sales@invivochem.cn
- Country:United States
- ProdList:6391
- Advantage:58
-
Supplier:
- Tel:+86-571-86626709<br/>+86-18157142896
- Email:cbc@coresyn.com
- Country:China
- ProdList:9984
- Advantage:58
-
Supplier:
- Tel: 13417589054
- Email:trendseenbio@gmail.com
- Country:China
- ProdList:11681
- Advantage:58
-
Supplier:
- Tel:+86-852-30606658
- Email:market18@leapchem.com
- Country:China
- ProdList:43340
- Advantage:58
1020149-73-8, SGI-1027Related Search:
- Inhibitors
- 抑制剂
- 合成有机化合物配体
- 细胞生物学试剂
- 小分子抑制剂,天然产物
- 小分子抑制剂
- C27H23N7O
- DNA甲基转移酶抑制剂(DNMT抑制剂)
- 化合物SGI-1027,10 MM DMSO 溶液
- SGI 1027,DNA甲基转移酶抑制剂
- SGI1027游离
- 化合物SGI-1027
- N-[4-[(2-氨基-6-甲基-4-嘧啶基)氨基]苯基]-4-(4-喹啉基氨基)苯甲酰胺
- 1020149-73-8
- SGI-1027, 10 mM in DMSO
- SGI-1027 USP/EP/BP
- SGI1027; SGI 1027
- CS-1144
- SGI-1027 N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
- N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide SGI-1027
- Benzamide, N-[4-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)-
- DNA Methyltransferase Inhibitor II
- N-[4-[(2-Amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)benzamide
- SGI-1027
- N-[4-[(2-amino-6-methylpyrimidin-4-yl)amino]phenyl]-4-(quinolin-4-ylamino)benzamide